“The Kaiser v. Pfizer trial provided two key lessons about drug company marketing: First, because drug companies fund most of the research about their drugs and control the resulting data, they can (and do) mislead physicians in order to increase sales. And, second, under our current system, it is more profitable for large pharmaceutical companiesContinue reading “RKS Health: Misleading Physicians to Increase Sales”
